The identification of risk factors for development of SBP (including ascitic fluid protein concentration 1.0 g/dL, variceal hemorrhage, and prior episode of SBP) has led to randomized controlled trials of prophylactic anti
The identification of risk factors for development of SBP (including ascitic fluid protein concentration 1.0 g/dL, variceal hemorrhage, and prior episode of SBP) has led to randomized controlled trials of prophylactic anti